Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference

GlobeNewswire May 26, 2021

Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conference

GlobeNewswire May 12, 2021

Agile Therapeutics Reports First Quarter 2021 Financial Results

GlobeNewswire May 4, 2021

Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting

GlobeNewswire April 30, 2021

CORRECTING AND REPLACING -- Agile Therapeutics

GlobeNewswire April 20, 2021

Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020

GlobeNewswire April 20, 2021

Agile Therapeutics to Present at Upcoming March Investor Conferences

GlobeNewswire March 5, 2021

Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors

GlobeNewswire March 1, 2021

Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021

GlobeNewswire February 19, 2021

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

GlobeNewswire January 4, 2021

Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 21, 2020

Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System, a New Non-Daily, Non-Invasive Contraceptive Patch

GlobeNewswire December 7, 2020

Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception

GlobeNewswire November 30, 2020

Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference

GlobeNewswire November 23, 2020

Agile Therapeutics Reports Third Quarter 2020 Financial Results

GlobeNewswire November 12, 2020

Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial Updates on Thursday, November 12, 2020

GlobeNewswire November 4, 2020

Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

GlobeNewswire September 22, 2020

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference

GlobeNewswire September 9, 2020

Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020

GlobeNewswire September 8, 2020

Agile Therapeutics Launches I'm So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control

GlobeNewswire September 2, 2020